PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0022661|chronic kidney disease |
| Sentences | 40 |
| PubMedID- 25288367 | Moreover, it has been noted that tissue et-1 concentration is more important than serum et-1 in predicting atherosclerosis in patients with chronic kidney disease (noshad et al. |
| PubMedID- 25296363 | We evaluated the relationship between osteoprotegerin levels and inflammatory markers, atherosclerosis, and mortality in patients with stages 3-5 chronic kidney disease. |
| PubMedID- 23644777 | Comment to sylwia olechnowicz-tietz et al.: the risk of atherosclerosis in patients with chronic kidney disease. |
| PubMedID- 20844474 | Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease. |
| PubMedID- 26101463 | Furthermore, epo retards the progression of atherosclerosis in chronic kidney disease patients [12]. |
| PubMedID- 26287243 | One of the possible causes of enhanced atherosclerosis in patients with chronic kidney disease (ckd) is the accumulation of uremic toxins. |
| PubMedID- 20940700 | The development of atherosclerosis in patients with chronic kidney disease (ckd) is severely accelerated leading to life-threatening cardiovascular (cv) events and its pathogenesis is different from that in the general population. |
| PubMedID- 19924100 | Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. |
| PubMedID- 20190248 | Background: chronic kidney disease (ckd) is associated with accelerated atherosclerosis and an inadequate inflammatory response which may account for the high morbidity and mortality observed in this population. |
| PubMedID- 23291030 | Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. |
| PubMedID- 20083473 | Background: endothelial dysfunction contributes to accelerated atherosclerosis in chronic kidney disease (ckd). |
| PubMedID- 20592243 | chronic kidney disease (ckd) is associated with accelerated atherosclerosis and cardiovascular disease, which is largely mediated by oxidative stress. |
| PubMedID- 20602330 | Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease. |
| PubMedID- 22937042 | Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 24085020 | Background and purpose: we aimed to clarify the association of chronic kidney disease (ckd) with carotid atherosclerosis and the impact of ckd on carotid atherosclerosis according to blood pressure categories in an urban general population. |
| PubMedID- 21071957 | Changes mediated by oxidative stress are thought to be involved with atherosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 23052640 | Saphenous vein aorto-coronary graft atherosclerosis in patients with chronic kidney disease: more plaque calcification and necrosis, but less vasoconstrictor potential. |
| PubMedID- 25166588 | We evaluated the relationship between osteoprotegerin levels and inflammatory markers, atherosclerosis, and mortality in patients with stages 3-5 chronic kidney disease. |
| PubMedID- 21823040 | Adiponectin (adpn) counteracts the inflammatory response of the endothelium, which plays an important role in the development of atherosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 23883412 | Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. |
| PubMedID- 20308998 | chronic kidney disease (ckd) is associated with development of atherosclerosis and premature death from cardiovascular disease. |
| PubMedID- 26427152 | Conclusions: our findings suggest that monitoring serum fgf-23 may be useful as a non-invasive indicator of subclinical atherosclerosis in patients with chronic kidney disease. |
| PubMedID- 24049268 | atherosclerosis in chronic kidney disease: striking while the iron is labile. |
| PubMedID- 24188108 | These compounds are currently considered as likely players in atherosclerosis in patients with chronic kidney disease [15]. |
| PubMedID- 21102540 | atherosclerosis in chronic kidney disease: the role of macrophages. |
| PubMedID- 21226275 | atherosclerosis is common in patients with chronic kidney disease (ckd), and cardiovascular disease (cvd) represents a major cause of death in these patients, especially, in patients with end-stage renal disease(esrd). |
| PubMedID- 25360490 | Cyanate is a uremic toxin responsible for the carbamylation of proteins, which has been implicated as playing a key role in accelerating the progression of atherosclerosis in patients with chronic kidney disease. |
| PubMedID- 22391251 | atherosclerosis in chronic kidney disease: lessons learned from glycation in diabetes. |
| PubMedID- 23483304 | The risk of atherosclerosis in patients with chronic kidney disease. |
| PubMedID- 22293998 | Carotid ultrasound for the early diagnosis of atherosclerosis in chronic kidney disease. |
| PubMedID- 22781707 | Aims: indoxyl sulfate, a uremic toxin, is considered a risk factor for arteriosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 23319980 | Fibrinogen is an acute phase reactant and is also associated with progression of atherosclerosis in patients with chronic kidney disease [21]. |
| PubMedID- 25782215 | Studies indicate that deficiency of vitamins and antioxidants in diet and also enhanced oxidative stress are cause of many complications for example: accelerated process of arteriosclerosis in patients with chronic kidney disease. |
| PubMedID- 23828708 | Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease. |
| PubMedID- 26536302 | Objective: this 8-year follow-up cohort study evaluated and compared the degree of coronary atherosclerosis in chronic kidney disease (ckd) according to the kidney disease: improving global outcomes (kdigo) classification using multivessel angioscopy and investigated the impact of the vulnerability of coronary arteries on the relationship between the classification and risk of acute coronary syndromes (acs). |
| PubMedID- 22907629 | Low serum pancreatic enzyme levels predict mortality and are associated with malnutrition-inflammation-atherosclerosis syndrome in patients with chronic kidney disease. |
| PubMedID- 26042415 | Background: chronic kidney disease (ckd) is associated with accelerated atherosclerosis and an increased risk of adverse cardiovascular disease (cvd) outcomes. |
| PubMedID- 21976741 | Background: the pathophysiology of aggravated atherosclerosis in chronic kidney disease (ckd) is still incompletely understood. |
| PubMedID- 25728732 | Background: chronic kidney disease (ckd) is associated with accelerated atherosclerosis and adverse cardiovascular outcomes, but mechanisms are unclear. |
| PubMedID- 23023631 | This association is partly explained by monckeberg's medial calcification, a characteristic atherosclerosis present in patients with advanced chronic kidney disease. |
Page: 1